Centiva Capital, LP Pfizer Inc Transaction History

Centiva Capital, LP

$4.65 Billion
Q4 2024

A detailed history of Centiva Capital, LP transactions in Pfizer Inc stock. As of the latest transaction made, Centiva Capital, LP holds 16,875 shares of PFE stock, worth $436,893. This represents 0.01% of its overall portfolio holdings.

Number of Shares

16,875

Previous 7,200 134.38%

Holding current value

$436,893

Previous $208,000 114.9%

% of portfolio

0.01%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$24.8 - $30.19 $353,251 - $430,026	14,244 Added 541.39%	16,875 $447,000
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $1.45 Million - $1.64 Million	-52,263 Reduced 95.21%	2,631 $76,000
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $871,848 - $1.02 Million	34,515 Added 169.37%	54,894 $1.54 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $527,612 - $605,867	20,379 New	20,379 $565,000
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $15,884 - $18,567	495 New	495 $16,000
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $352,382 - $458,750	8,946 New	8,946 $364,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $182,698 - $223,028	4,175 Added 206.27%	6,199 $271,000
Q2 2022 Aug 17, 2022	SELL	$46.53 - $55.17 $14 Million - $16.6 Million	-300,500 Reduced 99.33%	2,024 $106,000
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $13.4 Million - $15.9 Million	288,889 Added 2118.73%	302,524 $2.4 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $16.5 Million - $20.5 Million	-361,145 Reduced 96.36%	13,635 $706,000
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $14.6 Million - $21.6 Million	353,285 Added 1643.57%	374,780 $22.1 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $451,453 - $579,930	11,502 Added 115.1%	21,495 $923,000
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $106,257 - $120,372	-2,959 Reduced 22.85%	9,993 $391,000
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $1.88 Million - $2.12 Million	-56,123 Reduced 81.25%	12,952 $469,000
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $1.37 Million - $1.75 Million	-41,023 Reduced 37.26%	69,075 $2.54 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $977,106 - $1.15 Million	-30,775 Reduced 21.85%	110,098 $4.04 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $4.73 Million - $5.74 Million	-157,107 Reduced 52.72%	140,873 $4.61 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $6.81 Million - $9.73 Million	251,925 Added 547.01%	297,980 $9.73 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $1.09 Million - $1.24 Million	33,126 Added 256.21%	46,055 $1.8 Million
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $110,108 - $142,778	3,389 Added 35.52%	12,929 $464,000
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $328,843 - $398,867	9,540 New	9,540 $420,000

Others Institutions Holding PFE

# of Institutions

3,350

Shares Held

3.69B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account

Centiva Capital, LP Pfizer Inc Transaction History